Drug Class
anti-CD20 monoclonal antibody
Type
brand
Active Ingredient
ublituximab
📋Overview
Briumvi is a monoclonal antibody medication used in the management of certain autoimmune conditions, most notably multiple sclerosis. It works by targeting specific immune cells that are believed to play a role in the disease process. Briumvi is associated with reducing disease activity and the frequency of relapses in affected individuals. Its use reflects advances in therapies aimed at modifying the underlying immune response in chronic neurological disorders.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Briumvi
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.